Voyager Therapeutics Inc (VYGR)
8.81
+0.28
(+3.28%)
USD |
NASDAQ |
May 03, 16:00
8.81
0.00 (0.00%)
After-Hours: 20:00
Voyager Therapeutics Market Cap: 479.16M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 03, 2024 | 479.16M |
May 02, 2024 | 463.93M |
May 01, 2024 | 454.69M |
April 30, 2024 | 425.32M |
April 29, 2024 | 422.60M |
April 26, 2024 | 414.44M |
April 25, 2024 | 403.56M |
April 24, 2024 | 411.72M |
April 23, 2024 | 416.07M |
April 22, 2024 | 411.72M |
April 19, 2024 | 407.91M |
April 18, 2024 | 410.63M |
April 17, 2024 | 420.97M |
April 16, 2024 | 434.02M |
April 15, 2024 | 448.16M |
April 12, 2024 | 458.49M |
April 11, 2024 | 477.53M |
April 10, 2024 | 480.25M |
April 09, 2024 | 494.39M |
April 08, 2024 | 492.76M |
April 05, 2024 | 506.62M |
April 04, 2024 | 495.76M |
April 03, 2024 | 507.71M |
April 02, 2024 | 538.12M |
April 01, 2024 | 572.33M |
Date | Value |
---|---|
March 28, 2024 | 505.54M |
March 27, 2024 | 519.11M |
March 26, 2024 | 544.09M |
March 25, 2024 | 502.82M |
March 22, 2024 | 489.25M |
March 21, 2024 | 510.43M |
March 20, 2024 | 562.01M |
March 19, 2024 | 546.26M |
March 18, 2024 | 493.59M |
March 15, 2024 | 503.91M |
March 14, 2024 | 495.76M |
March 13, 2024 | 496.31M |
March 12, 2024 | 493.59M |
March 11, 2024 | 491.96M |
March 08, 2024 | 508.80M |
March 07, 2024 | 512.60M |
March 06, 2024 | 501.19M |
March 05, 2024 | 494.14M |
March 04, 2024 | 523.46M |
March 01, 2024 | 512.60M |
February 29, 2024 | 451.78M |
February 28, 2024 | 487.08M |
February 27, 2024 | 483.82M |
February 26, 2024 | 469.16M |
February 23, 2024 | 444.18M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
93.32M
Minimum
Oct 05 2021
1.038B
Maximum
Jul 03 2019
360.59M
Average
334.66M
Median
Mar 20 2023
Market Cap Benchmarks
Ligand Pharmaceuticals Inc | 1.308B |
United Therapeutics Corp | 11.64B |
MEI Pharma Inc | 20.39M |
Agios Pharmaceuticals Inc | 1.941B |
Macrogenics Inc | 978.31M |
Market Cap Related Metrics
PE Ratio | 2.908 |
PS Ratio | 1.586 |
Price to Book Value | 2.028 |
Price to Free Cash Flow | 5.310 |
Price | 8.81 |
Earnings Yield | 34.39% |
Operating PE Ratio | 3.249 |
Normalized PE Ratio | 2.908 |